Cargando…
Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells
Although testicular germ cell tumors are generally quite responsive to treatment with cisplatin, a small fraction of them acquire resistance during therapy. Even when cisplatin treatment is successful the patient is often left with a residual teratoma at the site of the primary tumor suggesting that...
Autores principales: | Abada, Paolo B., Howell, Stephen B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903721/ https://www.ncbi.nlm.nih.gov/pubmed/24475288 http://dx.doi.org/10.1371/journal.pone.0087444 |
Ejemplares similares
-
Regulation of Cisplatin Cytotoxicity by Cu Influx Transporters
por: Abada, Paolo, et al.
Publicado: (2010) -
The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells
por: Camacho-Moll, Maria E., et al.
Publicado: (2019) -
Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
por: Schmidtova, Silvia, et al.
Publicado: (2019) -
Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines
por: Roška, Jan, et al.
Publicado: (2020) -
Hypermethylation of genes in testicular embryonal carcinomas
por: Cheung, Hoi-Hung, et al.
Publicado: (2016)